Form 4 for IVVD Invivyd, Inc.
Accepted 2022-04-01 00:00:00 ET · period of report 2022-03-03 · accession 0000899243-22-013098 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-01 | 2022-03-03 | IVVD | Adimab, LLC | 10%, See Remarks | J - Other | — | -1.16M | 26.69M | -4% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-03 | J | D | 1,158,089 | — | 26,687,906 | D | — | — | (F1) In connection with the resignation of Dr. Tillman Gerngross from the Issuer's Board of directors, the Issuer repurchased 1,158,089 shares of restricted common stock from the Reporting Person for aggregate consideration of $2,316.18. |